Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samples
- 1 October 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 42 (10) , 741-742
- https://doi.org/10.1111/j.2042-7158.1990.tb06574.x
Abstract
A radioimmunoassay has been used to determine levels of the anticancer drug bleomycin in sewage treatment works effluent, river and potable water samples. Samples were concentrated 100-fold by lyophilisation and a final limit of detection of 5 ng L−1 was achieved. Concentrations of immunoreactive bleomycin of between 11 and 19 ng L−1 were found in the effluents but a lower concentration range < 5–17 ng L−1 was found in river and potable water samples. The risk to human health of ingesting water (in SE England) with such low levels of this cytotoxic drug appears to be minimal in relation to the normal chemotherapeutic doses administered (20–30 mg m−2).This publication has 10 references indexed in Scilit:
- A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in NursesNew England Journal of Medicine, 1985
- Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome.Journal of Epidemiology and Community Health, 1985
- The role of immunoassay in the analysis of microcontaminants in water samplesEcotoxicology and Environmental Safety, 1985
- The fate of pharmaceutical chemicals in the aquatic environmentJournal of Pharmacy and Pharmacology, 1985
- Delayed-release bleomycinCancer Chemotherapy and Pharmacology, 1984
- OCCUPATIONAL EXPOSURE TO CYCLOPHOSPHAMIDEThe Lancet, 1984
- The radioiodination of bleomycin using iodogenClinica Chimica Acta; International Journal of Clinical Chemistry, 1982
- Handling of injectable antineoplastic agents.BMJ, 1980
- Radioimmunoassay of bleomycin in plasma and urineBritish Journal of Cancer, 1977
- Assay of Methotrexate in the Presence of Its Decomposition Products and Other Folic Acid AnalogsJournal of Pharmaceutical Sciences, 1967